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Sllnllnal~ 
Class II major histocompatibility  complex (Ia)-bearing dendritic cells (DC) from airway epithelium 
and lung parenchyma express low-moderate antigen presenting cell (APC) activity when freshly 
isolated.  However,  this function is markedly upregulated during overnight culture in a manner 
analogous to epidermal Langerhans cells. The in vitro "maturation" process is inhibited by coculture 
with pulmonary alveolar macrophages (PAM) across a semipermeable membrane, and the degree 
of inhibition achieved can be markedly increased by the presence of tumor necrosis factor or. 
In addition, PAM-mediated suppression of DC function is abrogated via inhibition of the nitric 
oxide synthetase pathway. Functional maturation of the DC is accompanied by increased expression 
of surface Ia, which is also inhibited in the presence of PAM. Prior elimination of PAM from 
DC donors via intratracheal administration of the cytotoxic drug dichloromethylene diphosphonate 
in liposomes, 24-72 h before lung DC preparation, achieves a comparable upregulation of APC 
activity, suggesting that (consistent with the in vitro data) the resident PAM population actively 
suppresses the APC function of lung DC in situ. In support of the feasibility of such a regulatory 
mechanism, electron microscopic examination of normal lung fixed by intravascular  perfusion 
in the inflated  state  (which optimally preserves PAM in situ), revealed that the majority are 
preferentially localized in recesses at the alveolar septal junctions. In this position, the PAM are 
in intimate association  with the alveolar epithelial surface, and are effectively separated by as 
little as 0.2/~m from underlying interstitial spaces which contain the peripheral lung DC population. 
A similar juxtaposition of airway intraepithelial DC is demonstrated with underlying submucosal 
tissue macrophages, where the separation between the two cell populations is effectively the 
width of the basal lamina. 
p revious studies from this laboratory initially drew atten- 
tion to the role of dendritic cells (DC) 1 analogous to 
those described by Steinman and Nussenzweig (1), as the prin- 
cipal resident APC population in parenchymal lung tissue 
of rat (2). These observations were confirmed and extended 
by other investigators in a variety of species including human 
(3-9),  and were further extended to the epithelium of the 
conducting airways where class II MHC antigen (Ia)-bearing 
DC were shown to form a tightly meshed network com- 
parable  to that of epidermal Langerhans cells (10-12). 
1 Abbreviations used in this paper: DC, dendritic cell; DPDP, dichloro- 
methylene  diphosphate;  LNC, lymph  node  T cell; MMA, monomethyl- 
arginine; PAM, pulmonary  alveolar  macrophage;  RLN, regional  lymph 
node; VC, veil cell. 
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The epithelial surfaces within the respiratory system oc- 
cupied by these DC are continuously exposed to an array of 
pathogenic and nonpathogenic airborne antigens from the 
environment, and the maintenance of local homeostasis re- 
quires fine control of immunological processes, particularly 
those involving T  cell activation.  Active suppression of T 
cell responses to inert antigens plays an important role in local 
immunoregulation, at the antigen-specific level through the 
induction of immunological tolerance (13, 14) analogous to 
the phenomenon of oral tolerance to dietary antigens (15), 
and also via the generalized lymphocytostatic effects of en- 
dogenous tissue macrophages, in particular the pulmonary 
alveolar macrophage (PAM) population (for review see refer- 
ence 16). The latter inhibit T cell proliferation induced by 
lung and airway DC, prompting the suggestion that acces- 
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munomodulatory effects of local  macrophages (2,  6). 
Previous studies on DC from the epidermis and from lymph 
suggest that the antigen presentation functions of these cells 
are indeed actively regulated in vivo, as they perform poorly 
as APC when freshly isolated, but markedly upregulate their 
activity during overnight culture, with concomitant loss of 
processing capacity (17-19).  It has been suggested that this 
in vitro maturation process mimics the changes that normally 
occur during the migration of DC from tissue sites to re- 
gional LN, i.e., their prime function changes from antigen 
sampling, processing,  and storage at the periphery, to an- 
tigen presentation in the lymphoid tissues  (20). 
In the study below, we present direct evidence for the oper- 
ation of such a control mechanism in the lung and airway 
mucosa, and further demonstrate that the functional pheno- 
type of the DC is actively controlled by neighboring cells 
within these tissue microenvironments. Thus, DC freshly iso- 
lated from the tracheal epithelium and lung parenchyma ex- 
press only modest T cell stimulator), activity in MLR assays 
and in presentation of soluble protein antigens, and they dem- 
onstrate up to a 100-fold increase in stimulatory activity after 
overnight culture. Additionally, two lines of evidence indi- 
cate that the low APC activity of lung DC is actively main- 
tained in situ via diffusible mediators from resident PAM. 
First, selective in vivo elimination of PAM by intratracheal 
administration of a macrophage cytotoxic drug encapsulated 
in liposomes (21, 22) leads to the rapid enhancement of the 
APC activity of resident lung DC to approximate the high 
levels achieved by in vitro culture; and second,  the in vitro 
maturation of APC activity in these cells is inhibited by cocul- 
ture with PAM across a semipermeable membrane. The latter 
inhibition is amplified by TNF-ot, and is abrogated in the 
presence of an inhibitor of  macrophage nitric oxide production. 
Materials  and Methods 
Animals.  Specific  pathogen-free BN and WAG rats were ob- 
tained from the Animal Resources Centre, Murdoch University 
(Perth, Western Australia). They were barrier housed until used. 
Antibodies.  The mAbs, ED1 against an intracellular marker on 
macrophages and some DC (23), and ED2 against mature tissue 
macrophages (23) were provided gratis by Dr. C. Dijkstra, Depart- 
ment of Histology,  Vrije Universiteit,  and the mAbs Ox6 and Ox12 
(anti-class II  MHC and anti-r  L chains, respectively [24]) by 
Professor A. Williams (Medical Research Council Cellular Immu- 
nology Unit, Oxford, UK). Biotinylated sheep anti-mouse IgG 
and streptavidin-horseradish peroxidase (HRP)  conjugates were 
from Amersham (Sydney, Australia). 
Cytokines and Blocking Reagents.  Purified  natural murine GM- 
CSF, recombinant human TNF-~, human IL-lc~, and antimurine 
TNF-~/3 blocking antibody were from Genzyme Corp. (Boston, 
MA). Anti-TGF-/3  blocking antibody was from R & D Systems, 
Inc.,  (Minneapolis, MN).  Recombinant human  IL-6 was  from 
Boehringer Mannheim (Mannheim, Germany). Antimurine GM- 
CSF blocking antibody (25) was a kind gift from Drs. K. Takeda 
and K. Kumagai, Department of Microbiology, Tohoku Univer- 
sity  (Sendai, Japan). Indomethacin,  NG-monomethyl-arginine 
(MMA), and DMSO were from Calbiochem Corp. (LaJolla, CA). 
Visualization of Cells in Tissue Sections.  Frozen  sections of tra- 
chea and lung tissue were prepared and immunostained as described 
in detail in our earlier publications (6, 12), except that tissue fixa- 
tion with ethanol was performed  via intravascular  perfusion  through 
the pulmonary artery (at 40 cm HzO) after inflation of the lungs 
with air to 30 cm H20.  Lungs were then slowly deflated to 12 
cm H20 during perfusion. This technique has been shown to op- 
timally fix PAM in situ on the alveolar surface (26, 27). For elec- 
tron microscopy,  2.5% cacodylate-buffered  glutaraldehyde  was sub- 
stituted for ethanol in the fixation process. Tissue blocks were 
processed in the conventional fashion and embedded in Araldite  TM 
(TAAB, Reading, UK).  Ultra-thin  sections (600-800 nm) were 
strained with uranyl acetate and lead citrate before examination in 
a transmission electron microscope (model 410x; Phillips, Eind- 
hoven, The Netherlands). 
Cell  Preparation.  The  preparation of  enriched DC  from 
collagenase-digested  parenchymal  lung and tracheal epithelial sheets 
was as previously described (6). The procedure involves rigorous 
initial depletion of endogenous monocytes/macrophages  and B cells 
via slow elution from nylon wool, and finally, selection for ultra 
low-density cells on Percotl, yielding populations containing up 
to  35%  Ia + cells, many of which  demonstrate overtly pleio- 
morphic or veil cell (VC)-like morphology (6, 28). mAbs against 
surface r chains (for B cells) or the ED2 marker (tissue macrophages) 
stained <2% of the enriched DC populations. PAM were prepared 
by bronchoalveolar lavage as described (6). 
Precuhure of  DC.  Enriched  DC populations were cultured over- 
night in a variety of media including RPMI 1640, alone or sup- 
plemented with 10% FCS and Con A-activated  T cell supernatant 
(28). As reported previously (28), overall cell recovery from the 
cultures were variable (median 35%) and were lowest in cultures 
containing RPMI alone. Except where stated, the culture medium 
employed in preculture experiments reported below comprised 
RPMI 1640 plus 10% FCS. In some experiments, DC were in- 
cubated overnight in 24-h supernatant from PAM cultured at 2 
x  10~/ml in RPMI plus  10%  FCS, or in  FCS-supplemented 
R.PMI containing a variety ofcytokines (vide infra), and no consis- 
tent variations in DC recovery  after overnight incubation were ob- 
served. In one series of  experiments, DC were cultured in modified 
Boyden chambers (106 in 200 #1 medium, separated by a mem- 
brane (Millipore, Sydney,  Australia; pore size 0.22/zm) from PAM 
(2  x  106 in 300 #l medium). A proportion of this phase of the 
study was subsequently repeated employing culture chamber in- 
serts (Mitlicell CM; 0.4-/zm pore size; Millipore) to separate the 
DC and PAM populations. 
Antigen Presentation.  The assay  for presentation of soluble pro- 
tein antigens is as described  previously (6), employing lymph node 
T cells (LNC) from WAG rats immune to either BSA or OVA or 
Der p I antigen (low molecular weight allergen from the house 
dust mite; 29). LNC were initially depleted of endogenous APC 
before each assay, and their capacity to respond to soluble antigen 
without readdition of exogenous DC was checked within each ex- 
periment (6), and data was rejected if APC depletion was found 
to be incomplete. The assays  employed 4  x  10  s immune LNC in 
200 #1 RPMI 1640 supplemented with 5% syngeneic normal rat 
serum and 5  x  10 -s M 2-ME in triplicate wells, and varying 
numbers of  antigen-pulsed  enriched  DC (see below). The DC were 
X-irradiated (1,500 rad) immediately before addition to the T cell 
cultures. Proliferation was measured as [3H]thymidine  incorpora- 
tion into DNA at 96 h, and expressed as median A dpm per cul- 
ture after subtraction of background controls. Interculture varia- 
tion was minimal with SE of  replicates  being within 10% of means. 
Crossover specificity  controls were performed with BSA-immune 
T cells as previously described (6). The small number of experi- 
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unpulsed DC were rejected from the analyses. 
In vitro antigen pulsing of DC was performed via incubation 
in vitro at 2-500 #g/ml (for Derp I) or 1.0 mg/ml (BSA or OVA), 
followed by three washings in medium.  In vivo antigen pulsing 
was performed by exposure of WAG rats to an aerosol generated 
from a solution of 2.0 mg/ml OVA as described in (6). 
The rat MLR system employed is as detailed (30) with slight 
modification (28),  and involved coculture of 5  x  10  s responder 
cells (mesenteric LNC from WAG rats) with graded numbers of 
enriched X-irradiated lung DC from BN rats. 
In Vivo Depletion of  PAM.  The procedure involved intratracheal 
instillation of a suspension ofliposomes containing dichloromethy- 
lene diphosphonate (DMDP-liposomes), as described (21, 22). The 
liposomes spread rapidly throughout the surfactant layer, and within 
12 h 990% of PAM contain >5 droplets. The drug becomes cyto- 
toxic  after  release  in  the  phagolysozomes and  kills  the  PAM, 
depleting the resident population by up to >90%  within 24-48 
h ofliposome administration (21, 22). No translocation of DMDP 
or labeled liposomes below the epithelium has been observed, and 
morphometric analysis of immunostained lung sections from treated 
animals indicates that the procedure does not alter the density/sur- 
face phenotype of interstitial cell populations (21, 22).  No consis- 
tent changes in cell yield (including the enriched DC fraction) have 
been detected in lung digests from the liposome-treated animals. 
Flow Cytometry.  Cell surface expression of class II MHC (Ia) 
antigen was compared on fresh/cultured lung DC after immuno- 
staining with an Ox6-FITC conjugate, employing a flow cytom- 
eter (Epics;  Coulter Corp.,  Hiahah,  FL). 
Results 
APC Functions of Lung DC After In  Vivo Depletion of 
PAM.  In the experiments in Fig. 1 A, anesthetized BN rats 
were intratracheally inoculated with 200 ~1 of liposomes con- 
taining DMDP or PBS, or an equivalent volume of PBS alone, 
48 h before preparation of lung DC. These preparations, to- 
gether with equivalent  cells from intact controls,  were as- 
sayed  for APC  activity in  a one-way MLR as detailed  in 
Materials and Methods,  and it can be seen that the activity 
of DC from PAM-depleted animals was on the order of fivefold 
greater  than  controls. 
The experiments of Fig.  1 B illustrate the degree of en- 
hancement of the APC activity of lung DC,  as a function 
of time post DMDP-liposome administration.  The PAM popu- 
lation in these animals was reduced to '~30% of controls by 
the 24 h time point falling to 10% by 48-72 h, as in earlier 
studies (22), and it is evident that the maximal effects of PAM 
elimination  occur within  24 h. 
In Fig. 2, the effects of in vivo PAM elimination are exam- 
ined in relation to presentation of soluble protein antigens. 
In Fig. 2 A, control and PAM-depleted WAG rats were ex- 
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Figure 1.  Antigen presentation by lung DC in 
a primary MLR. Effect of prior depletion of PAM 
in DC donors. Semipurified  lung DC from groups 
of control or treated BN rats (n -  3) were titrated 
into  cultures of WAG LN cells, and resulting 
DNA synthesis determined as incorporation of 
[3H]thymidine at the 120-h time point. (.4) Lung 
DC pools were from untouched controls (11), and 
animals intratracheally inoculated 48 h previously 
with either PBS (O) or liposomes containing PBS 
([]) or DMDP (e). (B) MLR stimulatory activity 
of lung DC prepared from BN rats at varying 
periods  after  intratracheal  administration  of 
DMDP-liposomes. Zero-time control  (A);  24 h 
(e), 48 h (O), and 72 h (I) after administration. 
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Figure 2.  Presentation of a pro- 
tein antigen to immune T-cells by 
lung  DC.  (.4) Normal  control 
WAG rats (O) and WAG rats in- 
tratracheally inoculated 48 h previ- 
ously with DMDP-liposomes (e) 
were  exposed for 30  rain  to  an 
aerosol of OVA, and 1 h later lung 
DC  were  prepared  from  both 
groups and titrated into cultures of 
purified syngeneic OVA-immune  T 
cells. Resulting OVA-  induced T cell 
proliferation was determined as 3H-DNA synthesis at the 96-h time point and is shown as median Adpm per culture. (B) Lung DC from control 
(A) and PAM-depleted (A) WAG rats were pulsed in vitro with OVA antigen for 90 min, before titration into cultures of syngeneic OVA-immune 
T-cells. Data as per A. (C) Lung DC from intact WAG rats were prepared 1 h after antigen pulsing in vivo via 30 rain exposure of the donor animals 
to aerosolized  OVA. The DC were titrated onto cultures of syngeneic OVA-immune  T cells immediately after preparation (f-l) or after overnight preincu- 
bation in serum-supplemented growth medium (11). Data as per A. 
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Figure 3.  Modulation  of airway 
and lung DC function(s) in vitro. 
Stimulation of primary MLR re- 
sponses  of  WAG T cells  by DC from 
BN lung and airways. (,4) Tracheal 
epithelial DC titrated into allogeneic 
T cell cultures fresh (O) or after 
overnight precuhure (Q). (B) Lung 
DC into T cell cultures fresh (['-1), 
or  after overnight incubation in 
RPMI (&), RPMI supplemented 
with  10% FCS (A), or Con A- 
activated T cell  culture supernatant 
(11). (C) Lung DC into T cell cul- 
tures fresh (&), after overnight in- 
cubation in medium (C1), or in 
PAM culture supernatant (ll), or 
after preincubation in the presence 
of live AM across a semipermeable 
membrane (A). 
posed to an aerosol of OVA for 30 min,  and 1 h later,  lung 
DC were prepared from both groups and titrated into cul- 
tures of syngeneic OVA-immune T cells. DC from the PAM- 
depleted animals in these experiments displayed on the order 
of fourfold increased APC activity relative to intact controls. 
Comparable differences were also observed comparing lung 
DC from intact and PAM-depleted animals that were pulsed 
with  OVA antigen  in vitro (Fig.  2 B). 
Enhancement of  APC Activity of Lung DC by Overnight Cul- 
ture: Inhibition by Diffusible Mediators  from PAM.  In Fig.  2 
C, normal WAG rats were exposed to aerosolized OVA for 
30 rain. Lung DC were prepared from these animals 1 h later 
and cultured overnight in RPMI 1640 plus 10% FCS. A second 
group of animals were aerosol-exposed 1 d later,  and lung 
DC again prepared 1 h after exposure. These two lung DC 
preparations were titrated in parallel  into cultures of OVA- 
immune  syngeneic T  cells,  and 3H-DNA  synthesis deter- 
mined 4 d later.  It can be seen in Fig.  2 C  that  overnight 
culture of the antigen-exposed lung DC in the absence of 
macrophages leads to marked enhancement of APC activity 
comparable to that observed following in vivo PAM depletion. 
In vitro maturation of APC functions is also demonstrable 
employing primary MLR as the readout,  for both airway 
intraepithelial  DC (Fig.  3 A) and their counterparts in pa- 
renchymal lung tissue (Fig.  3 B; see also preliminary report 
in reference 28). Additionally,  the maturation process is in- 
hibitable by coculture with PAM across a semipermeable mem- 
brane (Fig. 3 C). Whereas the degree of stimulation of APC 
activity afforded via in vitro culture and the corresponding 
degree of sensitivity to PAM are variable from experiment 
to experiment,  the overall phenomenon per se is highly re- 
producible (Fig.  5; le~). However, attempts to duplicate the 
inhibitory effects of cocuhure with live PAM employing 24-h 
PAM culture supernatants met with extremely variable results, 
the best of which (equivalent to ~50% suppression) is shown 
in Fig. 3 C. In the majority of experiments, the supernatants 
were ineffective. 
The experiment in Fig. 4 demonstrates the activity of PAM 
in relation to processing and presentation of a soluble pro- 
rein antigen.  Thus, lung DC from normal BN rats were pulsed 
overnight with Der p I antigen in the presence and absence 
of PAM (transmembrane)  and/or recombinant human TNF-o~, 
before titration into cultures of Der p I-immune  syngeneic 
T  cells.  Overnight  incubation  of DC with Der p  I clearly 
facilitates  maturation  of APC function(s),  as evidenced by 
the high levels of T  cell proliferation induced by the pulsed 
cells. Cocuhure with PAM (transmembrane) reduces overall 
T  cell stimulatory  activity by '~50%  in  this  experiment, 
whereas in several others (Fig.  5), complete suppression was 
observed. The addition of high levels of TNF-ot (1,000 U/ml) 
to the DC cultures in this experiment resulted in a small reduc- 
tion (23%) in T cell stimulation, and synergized with trans- 
membrane PAM leading to ablation of APC activity. This 
synergistic effect of TNF-c~ was demonstrable over a series 
of experiments,  whereas  the effects  of TNF-cz  alone were 
highly variable,  ranging  from zero (in three quarters of ex- 
1~176  t  'o  so 
x 
.~  ~o 
~  2o 
1.25  2.5  5  10  20  40 
Lung DC per culture x 10"3 
Figure 4.  Presentation  of Der_p I antigen to immune T cells by lung 
DC: modulation by AM and TNF-ot. Lung DC were prepared from naive 
BN rats, and titrated onto cultures of purified syngeneic Pl-immune T 
cells after overnight incubation in medium alone (O), 500/xg/ml Pl an- 
tigen (A), P1 antigen plus TNF-o~ at 1,000 U/ml (O), P1 antigen plus 
transmembrane PAM ([~), or  P1  plus TNF-ot plus transmembrane 
PAM (A). 
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Figure 5.  Upregulation of the APC activity 
of lung DC by overnight preculture, and inhi- 
bition by transmembrane  AM. Summary data 
from a series of experiments  examining pre- 
sentation of aUoantigen and soluble protein an- 
tigens.  (MLR)  Format as per Fig.  3 C, and 
within each experiment stimulation indices (SI) 
for  DC  incubated  overnight (o/n) with  or 
without PAM were normalized  against  that 
achieved  with fresh DC. On rare occasions  lung 
DC preparation from ostensibly normal animals 
appeared  preacdvated  in vivo (note two ex- 
amples in this series shown with SI =  10 and 
30 when fresh) and this activity was also in- 
hibited by PAM. (Prom'n  antigen) Bracket of ex- 
periments involving presentation  of OVA or 
Derp I antigen to immune T cells. Format as 
per Fig. 4. Data for each experiment again nor- 
malized against SI observed with DC incubated 
overnight in medium alone (o/n). 
periments) up to a maximum of 35% reduction, leading to 
the condusion that this cytokine is one of a series of medi- 
ators which act in concert to downregulate the APC activity 
of the lung DC. 
Attempts to identify other possible regulatory cytokines 
in these coculture systems employing purified or recombinant 
IL-1, 1I.-6, GM-CSF, and blocking antibodies against GM- 
CSF and TGF-~, have failed to detect significant activity ei- 
ther alone or in various combinations.  Moreover, the addi- 
tion of high levels of blocking antibody against TNF-cr//~ 
to the PAM chamber did not abrogate suppression, reinforcing 
the view that this cytokine does not act alone in this system. 
Additionally, inclusion of 10/~g/ml of indomethacin in the 
cocultures or pretreatment of PAM donors by a combination 
of feeding and injection  (employing a protocol previously 
demonstrated by us to modulate other function of PAM [31]), 
failed to block the suppressive effects of PAM in this system, 
arguing against a significant role for prostaglandins. 
Fresh DC 
[~  medium 
DMSO + MMA 
PAM + DMSO 
[  PAM + DMSO + MMA 
2b  4h  &  sO 
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Figure  6.  Abrogation of the suppressive activity of PAM via inhibition 
of the nitric oxide synthetase pathway. Stimulation of primary MLR re- 
sponses of WAG T cells by BN lung DC after overnight coculture with 
PAM in the presence or absence of MMA. The MMA was dissolved in 
DMSO and diluted  500 times into the cultures  to a final concentration 
of 0.5 mM. Controls contained medium or DMSO alone. Culture format 
as per Fig. 3 C. The data shown  were replicated in three successive ex- 
periments. 
Abrogation of the Suppressive Effects of PAM Via Inhibition 
of the Nitric Oxide Synthetase Pathway.  Recent reports from 
a number of laboratories indicate that the in vitro "suppres- 
sive" activity of macrophages from lymphoid organs (32) and 
from lung (33) are attributable in part to the release of nitric 
oxide. The representative experiment shown in Fig. 6 em- 
ployed the same methodology, involving preculture of DC 
in the presence of transmembrane PAM, with or without 
the nitric oxide synthetase inhibitor MMA or the vehicle 
(DMSO) employed to solubilize the latter. It can be seen that 
incubation of lung DC in the presence of PAM inhibits the 
maturation of  MLtL-stimulating activity, and this inhibition 
is abrogated by the inclusion of  MMA in the coculture system. 
MMA modulation of macrophage suppression is reversible  by 
l.-arginine  but not D-arginine (data not shown) as detailed (32). 
Surface Expression of la on Lung DC during Overnight Cul- 
tur~  Table 1 illustrates two consecutive  experiments involving 
overnight culture of lung DC in the presence or absence of 
transmembrane PAM. As noted above, Ia expression in these 
preparations is restricted to a subpopulation  of cells which 
display characteristic VC- or DC-like morphology. Analysis 
Table  1.  Modulation  Ia Expression on Lung DC During 
Overnight Culture 
Surface Ia expression 
After overnight  After overnight 
Experiment  Fresh  incubation alone  incubation with PAM 
1  2.81  4.68  2.93 
2  2.31  4.03  3.21 
Lung DC were immunostained with Ox6 (anti-Ia)-FITC immediately 
after preparation  (fresh), or after overnight incubation  in one well of a 
Boyden chamber  (106 cells in 200/zl) adjacent to a second chamber con- 
taining medium (alone) or PAM (2  x  10  ~ in 300 #1). Data shown are 
mean fluorescence intensity. 
401  Holt et aL Figure  7.  Juxtaposition of DC and macrophage  populations  in rat  lung and airway tissues. (A) Interstitial  la + DC (arrow) straddling  an alveolar 
septal junction.  (B) ED1 + macrophages  (arrows) on the lumenal  surface of the alveolar space. A small interstitial  macrophage  (arrowhead) by contrast 
is situated  in a septal wall,  possibly within the vasculature. (C) Ia § DC within the tracheal epithelium  (E). The cell bodies lie close to the basement 
membrane  and their processes (arrows) interdigitate  between the epithelial cells. (D) Subepithelial macrophages  in trachea heavily stained via the ED2 
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immunostaining  with the mAb Ox6-FITC indicated increased 
Ia expression after overnight incubation consistent with that 
reported for epidermal Langerhans cells (34), and inhibition 
of this increase  occurred in the presence of PAM. 
In Vivo Relationship between DC and Macrophages in Respi- 
ratory Tract Tissues.  Fig. 7 comprises a series of photomicro- 
graphs which illustrate the juxtaposition of DC and macro- 
phage populations in the airway mucosa and the terminal 
air spaces. Figs.  7, A  and B illustrate immunostained sec- 
tions from the alveolar region of the rat lung fixed by vas- 
cular perfusion. Fig.  7 A  demonstrates an Ox6 + (Ia +) cell 
exhibiting typical pleiomorphic DC-like morphology, local- 
ized within the interstitium at the junction of three alveolar 
septa with cell processes extending into adjacent septal walls. 
Previous observations indicate that these ceils do not express 
the pan-macrophage markers ED1 or ED2 (6, 28) confirming 
their identity as DC,  and observation of Ox6-stained sec- 
tions from a series of animals indicated that >90% occur ei- 
ther within or directly adjacent to these alveolar septaljunc- 
tional zones (data  not shown). Fig.  7 B illustrates  ED1 + 
PAM adherent to the lumenal surface of the alveolar epithe- 
lium adjacent  to alveolar  septal junctions. A  variable but 
significant proportion of PAM detected in perfused-fixed rat 
lungs (in the range of 50-80%) appeared in these areas. This 
predilection of PAM to localize at septaljunctional areas has 
also been reported in human lung (27). 
Fig. 7, C and D show sections of airway mucosa stained 
with Ox6 and ED2, respectively. Note the Ox6 + (Ia §  DC 
within the airway epithelium (Fig. 7 C), and the heavily stained 
ED2 + mature tissue macrophages which are restricted to the 
adjacent submucosa, immediately beneath the epithelial base- 
ment membrane. We have previously demonstrated that DC 
represent the sole source of Ia-staining in normal airway epi- 
thelium of unstimulated specified pathogen free (SPF) rats 
(10, 12) and have confirmed by double staining that the ED2 
marker is restricted to mature tissue macrophages in rat re- 
spiratory tract (28) as has been reported for other tissues (23). 
Electron microscopic analysis of lungs fixed via intravas- 
cular perfusion (Fig. 7, E and F) confirmed that the majority 
of PAM (readily identifiable by their numerous dectron-dense 
intrathymic inclusions) are located at the alveolar junctional 
zones. The optimal preservation of morphology afforded by 
this method further revealed that PAM are spread out upon 
the type I epithelial lining and form part of the natural rounded 
contour of the alveolus by "filling" the crevices and recesses 
of the junctional zones (Fig. 7, E and F). Indeed, often these 
recesses are occupied by two or more PAM (Fig. 7 F), sepa- 
rated from the underlying interstitial cell population (which, 
based on immunoperoxidase staining, are known to be rich 
in DC) by only a thin attenuated covering of type I epithe- 
lium. As demonstrated in Fig. 7 F, the spatial separation be- 
tween PAM and adjacent interstitial DC (such as the "candi- 
dates" identified in Fig. 7, E and F) would be 0.2-1.0/zm. 
Discussion 
The primary function of DC is believed to be surveillance 
of mucosal/epithelial surfaces for foreign antigens not previ- 
ously encountered, as these cells have the unique attribute 
of presenting potent antigen-specific inductive signals to naive 
T cells (20). Their further likely specialization for uptake of 
soluble protein antigens and viruses (35) suggests that they 
play a major role in the etiology of allergic and infectious 
diseases in the respiratory system, particularly in view of the 
fact that they constitute the sole source of class II MHC (Ia) 
expression within the epithelium lining the airways during 
the steady state  (36). 
It has been postulated further that the induction of T cell 
immunity by DC is a distinctly biphasic process. In the first 
phase, DC function as "sentinels" in peripheral tissues, in- 
ternalizing and processing antigens, but paradoxically  they 
are unable to effectively present the processed antigens to T 
cells (17-20).  In the second phase, DC migrate to regional 
lymph nodes (RLN) and home to T cell zones, where they 
rapidly lose their capacity to process antigen and are trans- 
formed into potent APC. This functional maturation pro- 
cess can be mimicked by in vitro culture in appropriate media 
(17-20). 
In the context of the respiratory tract, such a model pro- 
vides a theoretically ideal mechanism for limiting local T cell 
responses at the fragile epithelial interface with the outside 
environment. In support of the operation of such a mecha- 
nism in the lung, the present study demonstrates that: (a) 
freshly isolated DC from this organ function relatively poorly 
in presentation of protein antigens to immune T cells, after 
brief antigen pulsing in vitro (Fig. 2 B) or in vivo (Fig. 2 
A); (b) this functional inadequacy is not due to defective an- 
tigen uptake, and moreover is reversible, as demonstrated by 
the marked improvement in APC activity achieved by over- 
night preincubation of antigen-pulsed DC before titration 
into cultures of immune T cells (Fig. 2 C), suggesting that 
it involves step(s) in processing and/or presentation; and (c) 
the capacity of lung DC to sensitize naive T cells in a pri- 
mary MLK demonstrates identical maturation in overnight 
culture (Fig.  3). 
Although it  is  currently believed  that  the presence  of 
processed peptide in Bjorkman's groove is necessary for rec- 
ognition of allogeneic class II MHC in a one-way MLR (37), 
the finding that MLR-stimulating activity improves markedly 
during overnight culture in serum-free medium (Fig. 3 B) 
argues against upregulation of capacity to internalize and cleave 
proteins per se as the sole basis for the functional maturation 
of lung DC. Furthermore, previous studies on DC from other 
mAb.  Note the lack of staining in the epithelium  (E). (A-D)  x 730. (E) Electron micrograph  of pulmonary alveolar macrophage  (M) spread upon 
the type I epithelial lining of an alveolus in the region of a septal junction, with its characteristic electron-dense cytoplasmic inclusions (lysosomes, 
phagosomes, and residual bodies). Note the candidate dendritic cell (de) in the interstitial tissue with irregularly shaped indented nucleus. (c) capillaries. 
x4000.  (F) Electron micrograph  of two pulmonary alveolar macrophages (M) at a septal junction, separated from a candidate dendritic  cell. (de) by 
the intervening  type I alveolar epithelial cell and basal lamina (arrowhead). x4000;  inset,  x17,000. 
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aspect of processing is maximal at the "peripheral tissue" stage 
of their life cycle (20). We have previously observed that over- 
night culture of lung DC upregulates surface expression of 
Ia (28; see also Table 1), and the density of Ia on the surface 
of APC has been shown to correlate directly with their potency 
in vitro (38).  However, previous studies indicating disparity 
between the kinetics of upregulation of Ia expression on pe- 
ripheral DC and upregulation of APC activity (34,  39,  40) 
suggest that additional factors are involved such as surface 
expression of cell-cell interaction molecules. 
The results of this study additionally provide evidence for 
a hitherto unrecognized level of regulation of DC functions, 
viz. active suppression of APC activity during their residence 
in peripheral tissues by (in the case of the lung) endogenous 
tissue macrophages. 
This evidence takes two forms. First, we demonstrate that 
selective in vivo depletion of PAM leads to rapid upregula- 
tion of the capacity of lung DC to present antigen to both 
naive (Fig.  1) and primed T cells (Fig.  2, A  and B), the de- 
gree of enhancement approximating that achieved by over- 
night preculture of isolated DC. Second, we demonstrate that 
the addition of PAM to the DC culture system across a semi- 
permeable membrane, strongly inhibits maturation of their 
APC functions (Figs. 3 C, 4, and 5), and is also capable of 
inhibiting the activity of DC which were already function- 
ally mature at the time of extraction (examples in ML1K results 
of Fig.  5). 
These observations provide an explanation for our earlier 
observations on rat lung DC (2, 6), and subsequent reports 
from other laboratories on DC from rat (5) and human lung 
(4,  7), which indicated that the presence of contaminating 
tissue macrophages (particularly contaminating PAM) pre- 
vented the in vitro demonstration of the APC activity of DC 
in lung tissue digests.  However, the results obtained with 
DMDP-liposomes argue that this inhibitory process is not 
confined to the test tube, but also occurs in the whole animal. 
Our data also provide a mechanism for the observed effects 
of PAM depletion on immune function in live animals. We 
have previously demonstrated that PAM-depleted mice and 
rats become hyperresponsive to antigenic stimulation in the 
lung and mount large local and systemic immune responses 
to low levels of inhaled antigens which do not elicit responses 
in intact animals (21, 22, 41). Thus, whereas this heightened 
responsiveness  may be partly attributable to release of local 
T cells from the lymphocytostatic effects of PAM (16), it ap- 
pears  likely that upregulation of local APC functions also 
plays an important role. 
In relation to the plausibility of such a control mechanism 
in vivo, it is valid to question whether diffusible signals from 
PAM are likely to effectively blanket the epithelial surfaces 
of the respiratory tract and hence the underling DC, particu- 
larly in view of the extremely large surface areas involved 
(up to 75 m 2 in the adult human). The general perception 
of PAM as a highly mobile population of phagocytic cells 
that constantly patrol the alveolar surface within the epithe- 
lial lining fluids,  scavenging inhaled particulates, is largely 
artefactual. Recent studies on the histological and ultrastruc- 
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tural appearance of the alveolar  septa after various fixation 
regimes (26, 27) indicate that the presence of apparently "flee" 
rounded PAM in the lumen of the airspaces represents an aber- 
ration caused by the common practice of intratracheal fixa- 
tion, which (like the process of bronchoalveolar lavage) dis- 
lodges cells from the alveolar surface and alters their shape 
and position. To obtain an accurate impression of the in vivo 
situation,  it is necessary to carry out fixation through the 
vascular bed at controlled perfusion pressures,  whilst main- 
taining the lungs in the inflated state. The application of this 
procedure to both rat and human lung reveals a very different 
distribution pattern, in which resident PAM are intimately 
associated  with epithelial surfaces in both the terminal air- 
spaces and the conducting airways (26,  27),  and in the case 
of human lung, virtually 100% of the PAM are localized at 
or directly adjacent to alveolar septaljunctional zones formed 
by adjoining septa (27). Electron microscope examination of 
perfused-fixed peripheral lung samples from the animals used 
in this study revealed an identical picture (Fig.  7, E and F), 
where the spatial separation between PAM and the interseptal 
connective tissues, and the majority of the DC are resident, 
can be as small as the width of a single type I alveolar epithe- 
lial cell (i.e.,  ~<0.2 #m). 
We have not as yet investigated the corresponding situa- 
tion in the conducting airways in detail, but initial observa- 
tions at the LM level (Fig. 7, C and D) indicate close associa- 
tion of intraepithelial DC with mature tissue macrophages 
in the underlying mucosa, and furthermore, these latter mac- 
rophages markedly inhibit in vitro APC activity, analogous 
to PAM (6). In addition, studies from other laboratories have 
demonstrated PAM tightly adherent to the airway epithe- 
lium on the lumenal surface (26),  suggesting that airway in- 
traepithelial DC may receive inhibitory signals  from both 
directions. 
The nature of the cytokine(s) that mediate these effects 
have not been rigorously defined. As noted in Materials and 
Methods we have tested a range of candidate mediators alone 
and in combination, but thus far can report consistent results 
only with respect to TNF-ot and nitric oxide. As noted above, 
TNF-ot alone displays weak activity in overnight cultures, 
but synergizes effectively with transmembrane PAM in in- 
hibiting functional maturation of the DC. mRNA for TNF-o~ 
is constitutively produced in high levels by PAM (42),  and 
inhalation of inflammatory stimuli leads to the rapid secre- 
tion of bioactive cytokine in vivo (43). This cytokine has also 
previously been demonstrated to maintain the viability of DC 
in vitro without promoting their functional maturation (44), 
and additionally has been demonstrated to stimulate migra- 
tion of peripheral DC to 1KLN after in vivo administration 
(45), suggesting that it may modulate the expression of ceU-cell 
interaction molecules on the DC surface. The striking effects 
observed with MMA in the culture system (Fig. 6) strongly 
suggest that nitric oxide plays a more direct role in the in- 
hibitory process, and the synergy observed with TNF-a may 
indicate differing (but complementary) targets on the DC 
for these two effector molecules, or (as suggested in 46, 47) 
stimulation of nitric oxide sexrretion  by TNF-ot. It is interesting 
to note in this context that the earlier literature on direct 
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that a dual signal was central to the mechanism of suppres- 
sion, one being derived from the PAM and the other from 
the T cells themselves (for review see reference 16), and more 
recent studies on nitric oxide-mediated suppression by PAM 
produced identical conclusions (33). It should be emphasized, 
however, that PAM-mediated suppression of DC functions 
proceeds in the absence of T  cells. 
A potential complicating factor in our DC maturation ex- 
periments,  which will be addressed in future studies, is the 
presence of contaminating cell types that copurify with the 
DC, and may secrete cytokines during in vitro incubation. 
In particular,  we have identified a source of GM-CSF in our 
cultures (data not shown), which is likely to be due to the 
presence of epithelial cells that  are known to be capable of 
secreting this cytokine (48). GM-CSF has been demonstrated 
to promote survival and maturation  of DC in culture (49) 
and may therefore modulate responsiveness to other cytokines, 
and follow-up experiments will be required accordingly, em- 
ploying purer lung DC preparations. 
We also plan to test the effects of inflammatory agents on 
the secretion of DC-modulatory mediators by PAM, partic- 
ularly in view of the recent demonstration by Bowers et al. 
(50) of the presence of both inhibitory and stimulatory ac- 
tivities in conditioned medium from LPS- and silica-exposed 
peritoneal  exudate macrophages. 
In conclusion, our study has demonstrated that, analogous 
to epidermal  Langerhans  cells,  DC  from lung  and  airway 
tissues sequester incoming antigens in situ, but do not ap- 
pear to be capable of efficiently presenting inductive signals 
to T cells until they undergo a subsequent maturation  step. 
We have further demonstrated that in the lung, they are main- 
tained  in this functional  state via the secreted products  of 
adjacent macrophages,  which include nitric oxide and TNF-ot. 
Experiments  with cell preparations  from other tissues will 
be required to ascertain whether this is an intrinsic compo- 
nent  of the immunobiology of the overall  DC  system, or 
whether it represents an adaptive response peculiar to respi- 
ratory tract  epithelial  microenvironments. 
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